Latest News

Home News Newsletter Prostate Specific Antigen

Prostate Specific Antigen

Prostate Specific Antigen (PSA), is a protein secreted by the acinar cells of the Prostate, and is highly specific for the Prostate. Serum PSA levels are useful for determining the extent of Prostate Cancer, and assessing the response to therapy. However, it is NOT Prostate cancer specific and other conditions such as: Benign Prostatic hyperplasia (BPH) or Prostatitis can affect PSA levels.

  • PSA is commonly used as a tool to detect Prostate Cancer, but its role in screening programmes is widely debated and controversial.

Clinical utility:

PSA has a half-life of 2.2 days. Where levels are increased by different Benign conditions, the time to return to baseline levels is variable.

The common causes of an elevated PSA are:

A) Perineal trauma:

Mechanical manipulation of the Prostate during biopsy or transurethral resection of the Prostate (TURP) can significantly affect PSA. In a study of 101 men who underwent one of these procedures, it was determined that PSA levels should not be measured for at least 6 weeks thereafter. In the same study, the median change in PSA level was of a lesser magnitude following Cystoscopy.

  • Digital Rectal Examination (DRE) has minimal effect on PSA levels. (Leading to transient elevations of 0.26 – 0.4 ng/ml).
  • Sexual activity can also elevate PSA levels by approximately 0.4 - 0.5 ng/ml.

Download to read more

See more Newsletter items

Cerba Lancet Africa on the continent

Botswana Eswatini Ethiopia Gabon Ghana Ivory Coast Kenya Mozambique Nigeria Rwanda Tanzania Uganda Zambia Zimbabwe